Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160026/S065

LIFEPAK 35 monitor/defibrillator

Physio-Control, Inc. · Decision date Feb 23, 2026

FDA DECISIONP160026/S065

What did the FDA approve?

FDA records P160026/S065 as a supplement to PMA P160026, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Feb 23, 2026.

FDA approval order statement

addition of SpO2 module and Non-invasive blood pressure (NIBP) software changes
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Feb 23, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P160026/S065
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
APPR
Decision date
Feb 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

For the original device and its historical approval scope, see PMA P160026. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160026 · Original PMA

    LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

  2. P160026/S062 · Related supplement

    LIFEPAK 1000 defibrillator

  3. P160026/S065 received

    Application receipt date recorded by FDA.

  4. P160026/S064 · Related supplement

    LIFEPAK 35 monitor/defibrillator

  5. P160026/S063 · Related supplement

    LIFEPAK 35 Defibrillator/monitor

  6. P160026/S065 · FDA decision

    Real-Time Process

  7. P160026/S066 · Related supplement

    LIFEPAK 35 monitor/defibrillator

  8. P160026/S067 · Related supplement

    LIFEPAK 15 monitor/defibrillator

  9. P160026/S068 · Related supplement

    LIFEPAK 15 monitor/defibrillator

  10. P160026/S070 · Related supplement

    LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

  11. P160026/S071 · Related supplement

    LIFEPAK 35 monitor/defibrillator

  12. P160026/S072 · Related supplement

    Physio-Control LIFEPAK35 monitor/defibrillator

  13. P160026/S069 · Related supplement

    LIFEPAK 35 monitor/defibrillator

  14. P160026/S073 · Related supplement

    LIFEPAK 15 monitor/defibrillator

  15. P160026/S074 · Related supplement

    LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

  16. P160026/S076 · Related supplement

    LIFEPAK 35 monitor/defibrillator

Timeline entries are records held by MedtechLedger for P160026. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160026

Product / regulatory recordCompanyPathwayDecision dateSource
Physio-Control, Inc.PMA approvalJul 2, 2018FDA
Physio-Control, Inc.PMA supplementOct 14, 2025FDA
Physio-Control, Inc.PMA supplementNov 21, 2025FDA
Physio-Control, Inc.PMA supplementDec 4, 2025FDA
Physio-Control, Inc.PMA supplementMar 5, 2026FDA
Physio-Control, Inc.PMA supplementMay 6, 2026FDA
Physio-Control, Inc.PMA supplementJun 25, 2026FDA
Physio-Control, Inc.PMA supplementJul 30, 2026FDA
Physio-Control, Inc.PMA supplementAug 6, 2026FDA
Physio-Control, Inc.PMA supplementAug 28, 2026FDA
Physio-Control, Inc.PMA supplementSep 2, 2026FDA
Physio-Control, Inc.PMA supplementSep 10, 2026FDA
Physio-Control, Inc.PMA supplementSep 24, 2026FDA
Physio-Control, Inc.PMA supplementOct 29, 2026FDA

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Physio-Control, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11811 Willows Rd. NE, Redmond, WA, 98052

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records